These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17868274)

  • 21. Phenotypic isoniazid resistance and associated mutations in pediatric tuberculosis.
    Jhanjhria S; Kashyap B; Gomber S; Gupta N; Hyanki P; Singh NP; Khanna A; Sharma AK
    Indian J Tuberc; 2019 Oct; 66(4):474-479. PubMed ID: 31813434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antituberculous therapy and acute liver failure.
    Durand F; Pessayre D; Fournier M; Belghiti J; Erlinger S; Bernuau J
    Lancet; 1995 May; 345(8958):1170. PubMed ID: 7723555
    [No Abstract]   [Full Text] [Related]  

  • 23. Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events.
    Bachir M; Guglielmetti L; Tunesi S; Billard-Pomares T; Chiesi S; Jaffré J; Langris H; Pourcher V; Schramm F; Lemaître N; Robert J;
    Int J Infect Dis; 2021 Jun; 107():86-91. PubMed ID: 33823278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    Nagu TJ; Aboud S; Matee MI; Maeurer MJ; Fawzi WW; Mugusi F
    J Antimicrob Chemother; 2017 Mar; 72(3):876-881. PubMed ID: 27999054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.
    Idilman R; Ersoz S; Coban S; Kumbasar O; Bozkaya H
    Liver Transpl; 2006 Sep; 12(9):1427-30. PubMed ID: 16933231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of surveillance mycobacterial cultures after liver transplantation.
    Torre-Cisneros J; de la Mata M; Rufian S; Villanueva Marcos JL; Gutierrez Aroca J; Casal M; Miño G; Pera C
    Transplantation; 1995 Nov; 60(9):1054-5. PubMed ID: 7491683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
    Farrell FJ; Keeffe EB; Man KM; Imperial JC; Esquivel CO
    Dig Dis Sci; 1994 Oct; 39(10):2255-9. PubMed ID: 7924752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and management of latent tuberculosis in liver transplant patients.
    Jafri SM; Singal AG; Kaul D; Fontana RJ
    Liver Transpl; 2011 Mar; 17(3):306-14. PubMed ID: 21384513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis.
    Chierakul N; Saengthongpinij V; Foongladda S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S86-90. PubMed ID: 24772584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of drug resistance on the generation of secondary cases of tuberculosis.
    Burgos M; DeRiemer K; Small PM; Hopewell PC; Daley CL
    J Infect Dis; 2003 Dec; 188(12):1878-84. PubMed ID: 14673768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
    Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD
    Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprophylaxis with isoniazid in liver transplant recipients.
    Fábrega E; Sampedro B; Cabezas J; Casafont F; Mieses MÁ; Moraleja I; Crespo J; Pons-Romero F
    Liver Transpl; 2012 Sep; 18(9):1110-7. PubMed ID: 22645064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.
    Jensen TO; Darley DR; Goeman EE; Shaw K; Marriott DJ; Glanville AR
    Transpl Infect Dis; 2016 Oct; 18(5):782-784. PubMed ID: 27459235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute liver failure caused by isoniazid in a child receiving carbamazepine.
    Berkowitz FE; Henderson SL; Fajman N; Schoen B; Naughton M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):603-6. PubMed ID: 9661830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activity.
    Ruiz P; Rodríguez-Cano F; Zerolo FJ; Casal M
    Microb Drug Resist; 2003; 9(3):313-6. PubMed ID: 12959411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoniazid-induced recurrent acute pancreatitis.
    Pandey AS; Surana A
    Trop Doct; 2011 Oct; 41(4):249-50. PubMed ID: 21873403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary tuberculosis in children. 1. Incidence of primary drug-resistant disease in 332 children observed between the years 1961 and 1964 at the Kings County Medical Center of Brooklyn.
    Steiner M; Cosio A
    N Engl J Med; 1966 Apr; 274(14):755-9. PubMed ID: 17926880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-multidrug-resistant Mycobacterium tuberculosis Beijing strain associated with disseminated tuberculosis in a pet dog.
    Botelho A; Perdigão J; Canto A; Albuquerque T; Leal N; Macedo R; Portugal I; Cunha MV
    J Clin Microbiol; 2014 Jan; 52(1):354-6. PubMed ID: 24153119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
    Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
    Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.